Chalcone derivatives: promising starting points for drug design; QSAR-based virtual screening: advances and applications in drug discovery; Pred‐hERG: A novel web‐accessible computational tool for predicting cardiac toxicity; 4D-QSAR: perspectives in drug design; In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery; Assessing the performance of 3D pharmacophore models in virtual screening: how good are they?; Alarms about structural alerts; A critical overview of computational approaches employed for COVID-19 drug discovery; CoMPARA: collaborative modeling project for androgen receptor activity; Tuning HERG out: antitarget QSAR models for drug development; QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity; Déjà vu: stimulating open drug discovery for SARS-CoV-2; Natural products as leads in schistosome drug discovery; Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds; Pred-skin: a fast and reliable web application to assess skin sensitization effect of chemicals; Open drug discovery for the Zika virus; Virtual screening strategies in medicinal chemistry: the state of the art and current challenges; Discovery of new anti-schistosomal hits by integration of QSAR-based virtual screening and high content screening; Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization; 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models.
